Nasdaq Hits Fresh Ground on Chip and Software Strength as Dow, Small Caps Lag for the Week
Company updates paired a defense contract and completed investments with lower Integra guidance linked to facility flooding.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
RTX (RTX) business Raytheon secured a five-year Standard Missile-6 contract valued up to $24.4 billion, with two additional option years. The Nasdaq gained 0.44% for the week, while the Dow, S&P 500 and Russell 2000 declined.
Integra LifeSciences (IART) lowered 2026 revenue and adjusted earnings guidance, citing continued effects of July flooding at its Cincinnati facility. Trilogy Metals (TMQ) closed a $35.6 million government equity investment on September 11, 2026; quarterly net income turned positive, but its nine-month loss widened.
Phillips Edison & Company (PECO) reaffirmed earnings guidance and raised its 2026 acquisitions target to $600 million–$700 million. Axogen (AXGN) completed its BioCircuit Technologies acquisition and expects approximately $6 million in fourth-quarter 2026 revenue and approximately $34 million in 2027 revenue from BioCircuit.
How this balance works
Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.
It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.
Rhea-AI Sentiment measures something else, the tone of the wording.
Hollow bars mark forward-looking points. How the balance works
Positive
- Major pointRTX's Raytheon secured an up to $24.4 billion contract for five years, with two additional option years. 9.8% of market cap
- Moderate pointTrilogy Metals closed a $35.6 million Department of War equity investment on September 11, 2026.
- Moderate point. Forward-looking: it has not happened yet and may not happen.Phillips Edison raised 2026 gross acquisitions guidance to $600 million–$700 million from $500 million–$600 million.
- Moderate pointPhillips Edison acquired $459.7 million in assets year to date through September 30, 2026.
- Moderate pointAxogen completed its BioCircuit Technologies acquisition, adding the FDA-cleared NerveTape device for sutureless peripheral nerve repair.
- Moderate point. Forward-looking: it has not happened yet and may not happen.Axogen expects BioCircuit revenue of approximately $6 million in fourth-quarter 2026 and approximately $34 million in 2027.
8 minor points
- Minor pointRTX's Raytheon invested in workforce growth, industrial partnerships and automation to support higher output.
- Minor pointTrilogy Metals' third-quarter net income of $0.2 million compares with a $1.7 million year-earlier loss.
- Minor point. Forward-looking: it has not happened yet and may not happen.Phillips Edison's reaffirmed 2026 Nareit FFO per diluted share guidance midpoint represents 6.3% year-over-year growth.
- Minor point. Forward-looking: it has not happened yet and may not happen.Phillips Edison's reaffirmed 2026 Core FFO guidance midpoint represents 6.2% year-over-year growth.
- Minor point. Forward-looking: it has not happened yet and may not happen.Phillips Edison's reaffirmed 2026 same-center net operating income guidance midpoint represents 3.7% growth.
- Minor point. Forward-looking: it has not happened yet and may not happen.Axogen's 2026 guidance remains at least 24% revenue growth, excluding BioCircuit's expected contribution.
- Minor point. Forward-looking: it has not happened yet and may not happen.Axogen continues to expect gross margin of at least 73% for the full year.
- Minor point. Forward-looking: it has not happened yet and may not happen.Axogen continues to expect to be free cash positive for the full year.
Negative
- Major point. Forward-looking: it has not happened yet and may not happen.Integra lowered 2026 revenue guidance to $1.634 billion–$1.654 billion from $1.654 billion–$1.695 billion.
- Moderate pointTrilogy Metals' nine-month net loss widened to $13.2 million from $7.5 million in the prior-year period.
- Minor point. Forward-looking: it has not happened yet and may not happen.Integra lowered 2026 adjusted EPS guidance to $2.30–$2.40 from $2.40–$2.50.
- Minor pointIntegra cited continued impact from July flooding at its Cincinnati facility on third-quarter results.
AI-generated analysis. How Rhea-AI works. Not financial advice.
The Dow Jones Industrial Average closed at 51,094.96, up
The CBOE Volatility Index fell to 15.58, down 0.81 on the day and 0.49 for the week, while the Nasdaq-100 Volatility Index closed at 21.93, down 0.58 on the day but up 1.06 for the week. WTI crude oil dropped
Gold eased
The full report includes the week's key support and resistance levels for each major index along with additional company news and sentiment from the week.
CONTINUED... Read this and more news for RTX (NYSE: RTX), Integra LifeSciences Holdings Corporation (Nasdaq: IART), Trilogy Metals Inc. (NYSE American: TMQ), Phillips Edison & Company, Inc. (Nasdaq: PECO), and Axogen, Inc. (Nasdaq: AXGN) at: https://stockpreachers.com/articles/big-tech-carries-the-tape-while-the-dow-limps-to-friday/
In other industry developments and happenings in the market this week include:
RTX (NYSE: RTX) Raytheon, an RTX business, secured a five-year contract with two additional option years valued up to
"SM-6's multi-mission capability is vital to our customer, and Raytheon is intensely focused on meeting the demand," said Phil Jasper, Raytheon President. "By continuously investing in our operations and facilities, we are removing constraints and boosting capacity to ensure we deliver this critical capability our sailors depend on."
The company said SM-6 is the only combat-proven weapon capable of anti-air warfare, anti-surface warfare and ballistic missile defense, and has invested in workforce growth, industrial partnerships and automation to support higher output. Read the release.
Integra LifeSciences Holdings Corporation (Nasdaq: IART) Integra LifeSciences provided preliminary third quarter results and updated full-year 2026 guidance, citing continued impact from a July flooding event at its
"Our third quarter results were impacted by the July flooding event at our
The company updated its full-year 2026 revenue outlook to a range of
Trilogy Metals Inc. (NYSE American: TMQ) Trilogy Metals reported a cash balance of
The company reported third quarter net income of
"The third quarter and the weeks that followed have been transformational for Trilogy Metals," said Tony Giardini, President and CEO. "With a defined permitting timeline, the investment by the
Phillips Edison & Company, Inc. (Nasdaq: PECO) Phillips Edison & Company reaffirmed its full year 2026 earnings guidance and increased its gross acquisitions guidance to a range of
The reaffirmed midpoint of full year 2026 Nareit FFO per diluted share guidance represents
"We're pleased to reaffirm our guidance for full year 2026 Core FFO per share growth, which reflects
Axogen, Inc. (Nasdaq: AXGN) Axogen completed its acquisition of BioCircuit Technologies, adding NerveTape, which the company describes as the first FDA cleared device for sutureless peripheral nerve repair.
"NerveTape represents a new standard of care as the first sutureless nerve repair option, one that is simpler, faster, and more effective than microsuturing," said Michael Dale, President and Chief Executive Officer of Axogen.
The company expects BioCircuit to contribute approximately
Contact Information:
Media Contact: info@stockpreachers.com
DISCLAIMER: Nothing in this article should be considered as personalized financial advice. We are not licensed under securities laws to address your particular financial situation. No communication by our employees to you should be deemed as personalized financial advice. Please consult a licensed financial advisor before making any investment decision. This is a market commentary and is not a paid advertisement. This article is being distributed by Stock Preachers, which is wholly owned and operated by Market Equities Limited ("MEL"), a company incorporated under the laws of Ireland. This is an independent market commentary published on a non-paid basis. MEL has not been paid any fee by any company mentioned in this article for its production or distribution, and MEL has no advertising or digital media agreement with any company mentioned in this article. The companies mentioned have not reviewed or approved this article. Market Equities and its owners, operators, directors, and affiliates may, from time to time, hold positions in securities mentioned in this article or in the broad-market index funds that track them, and reserve the right to buy, sell, or hold such securities at any time without further notice. Information in this article was obtained from sources believed to be reliable, including company news releases and public market data, but its accuracy cannot be guaranteed. Market data is as of the time stated and may be delayed. Portions of this commentary were produced with the assistance of automated tools from that data and reviewed against it. Investing in securities involves risk, including the possible loss of some or all of your investment. Technical analysis describes past price and volume behavior and does not predict future results; support and resistance levels can fail at any time. References to the companies named in this article are provided solely as market and sector context and as summaries of each company's own public news releases. No partnership, affiliation, or endorsement is implied, and nothing in this article is a recommendation to buy, sell, or hold any security. Quotations attributed to company executives are reproduced from those companies' own news releases. Forward-Looking Statements: This article may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, including statements made by the companies mentioned in their own news releases. Such statements involve risks and uncertainties, and actual results may differ materially. Readers should review each company's filings with the SEC and applicable Canadian securities regulators. Eagle Eye is an investor signal-intelligence platform affiliated with the publisher of this article. Eagle Eye is not a broker-dealer, and nothing it provides is investment advice. Data may be delayed. Always do your own research.
View original content to download multimedia:https://www.prnewswire.com/news-releases/nasdaq-hits-fresh-ground-on-chip-and-software-strength-as-dow-small-caps-lag-for-the-week-302897635.html
SOURCE Stock Preachers
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What are the value and duration of RTX's Standard Missile-6 contract?
Raytheon, an RTX business, secured a contract valued up to $24.4 billion for five years, with two additional option years. The contract covers Standard Missile-6 interceptors for the U.S. Navy.
What preliminary third-quarter 2026 results does Integra LifeSciences expect?
Integra expects revenue of approximately $410 million to $412 million and adjusted earnings per diluted share of $0.55 to $0.59. Its updated full-year outlook still includes expected operating cash flow of $190 million to $200 million.
What was Trilogy Metals' cash position before its government equity investment closed?
Trilogy Metals had $31.2 million in cash and adjusted working capital of $30.3 million as of August 31, 2026. Those balances precede the September 11, 2026 closing of the $35.6 million Department of War equity investment.
How much did Phillips Edison sell in assets during 2026?
Phillips Edison sold $174.0 million in assets year to date through September 30, 2026.